Skip to content
healthcare.dev
Get a free key

TROGARZO

NDC 62064-122, ibalizumab, injection, solution, from Theratechnologies Inc..

Product NDC
62064-122
Status
Listed
Labeler
Theratechnologies Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761065
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62064-122 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IBALIZUMAB150 mg/mL

Pharmacologic classes

Antibodies, Monoclonal, Humanized [CS]; CD4-directed Antibody Interactions [MoA]; CD4-directed Blocking Antibody [EPC]; HIV 1 Post-attachment Fusion Inhibitors [MoA]; Human Immunodeficiency Virus 1 Post-attachment Fusion Inhibitor [EPC]

Package NDCNDC-11Package
62064-122-02620640122022 VIAL, SINGLE-USE in 1 CARTON (62064-122-02) / 1.33 mL in 1 VIAL, SINGLE-USE (62064-122-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c548ad82-9d1f-4d16-95b6-4e6106badf43

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=62064-122

Use it

Look up 62064-122 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62064-122 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62064-122. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.